OCS

Oculis Holding AG Ordinary shares (OCS)

US
$ 17.452.05%

Price Chart

Key Statistics

Market Cap
$ 928.24M
P/E Ratio
0.00
Revenue (TTM)
$ 749K
Volume
56.37K
52W High
$ 23.08
52W Low
$ 10.79
Dividend Yield
0.00%
Beta
0.10

Technicals

50-Day MA
18.0506
200-Day MA
16.671
52 Week High
23.08
52 Week Low
10.79

About OCS

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally. The company's lead product candidate .

Employees
49
Headquarters
Zug, Switzerland
CEO
Dr. Riad Sherif M.B.A., M.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg